Lv31
205 积分 2021-04-11 加入
Efficacy and safety of low-dose Interleukin-2 in the treatment of moderate to severe bullous pemphigoid: a single center perspective-controlled trial
4小时前
待确认
The role of C4d expression in the diagnosis of bullous pemphigoid: a clinical and histopathological study
1个月前
已完结
Identification of gut microbiota dysbiosis in bullous pemphigoid under different disease activity
1个月前
已完结
Serum thymus and activation‐regulated chemokine is a surrogate marker for bullous pemphigoid disease activity
1个月前
已完结
IL-27 as a novel biomarker for pruritus in nodular prurigo and bullous pemphigoid
1个月前
已完结
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are positively correlated with disease activity of bullous pemphigoid
1个月前
已完结
IL-13 Genetic Susceptibility to Bullous Pemphigoid: A Potential Target for Treatment and a Prognostic Marker
1个月前
已完结
Analysis of IL‐10 and IL‐35 in dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid
1个月前
已完结
Interleukin‐36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoid
1个月前
已完结
Periostin in Bullous Pemphigoid: A Potential Biomarker of Disease Activity and Severity
1个月前
已完结
皖公网安备34019202002308
